AbramsonD.H., MarrB.P., DunkelI.J., BrodieS., ZaborE.C., DriscollS.J., et al.Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br. J. Ophthalmol., 96:499–502, 2012.
2.
SuzukiS., and KanekoA.Management of intraocular retinoblastoma and ocular prognosis. Int. J. Clin. Oncol., 9:1–6, 2004.
3.
SmithS.J., and SmithB.D.Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review. Br. J. Ophthalmol., 97:1231–1236, 2013.
4.
GhassemiF., and ShieldsC.L.Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol., 130:1268–1271, 2012.
5.
MarrB.P., DunkelI.J., LinkerA., and AbramsonD.H.Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity. Br. J. Ophthalmol., 96:881–883, 2012.
6.
HarbourJ.W., MurrayT.G., HamasakiD., CicciarelliN., HernandezE., SmithB., et al.Local carboplatin therapy in transgenic murine retinoblastoma. Invest. Ophthalmol. Vis. Sci., 37:1892–1898, 1996.
7.
NemethK.M., FedericoS., CarcabosoA.M., ShenY., SchaiquevichP., ZhangJ., et al.Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma. Cancer., 117:421–434, 2011.
8.
PochopP., DarsovaD., UhlikJ., LestakJ., KukackaJ., KodetovaD., et al.Retinal toxicity after repeated intravitreal carboplatin injection into rabbit eyes. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czechoslov., 2012 [Epub ahead of print]; DOI: 10.5507/bp.2012.106.
9.
RezaKarkhaneh, et al.Toxic effect of intravitreal carboplatin detected by flattened electeroretinogram in a patient with retinoblastoma treated by chemoreduction and local treatment. Iran J. Ophthalmol., 22:57–60, 2010.
10.
SmithS.J., PulidoJ.S., SalomãoD.R., SmithB.D., and MohneyB.Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Br. J. Ophthalmol., 96:1073–1077, 2012.